M. Manasterski

发表

Successful treatment of delayed pressure urticaria with anti-TNF-alpha.

M. Maurer, S. Philipp, M. Friedrich, 2007, The Journal of allergy and clinical immunology.

HLA class I alleles and responsiveness of melanoma to immunotherapy with interferonalpha (IFN-α) and interleukin-2 (IL-2)

C. Scheibenbogen, S. Suciu, U. Keilholz, 1994, Melanoma research.

In vitro expansion and analysis of T lymphocyte microcultures obtained from the vaccination sites of cancer patients undergoing active specific immunization with autologous Newcastle-disease-virus-modified tumour cells

P. Schlag, R. Zawatzky, V. Schirrmacher, 1993, Cancer Immunology, Immunotherapy.

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

J. Roemmler-Zehrer, K. Reich, N. Magnolo, 2021, Dermatology and Therapy.

In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients.

P. Schlag, P. Möller, V. Schirrmacher, 1991, European journal of cancer.

Postoperative active specific immunization in colorectal cancer patients with virus‐modified autologous tumor‐cell vaccine. First clinical results with tumor‐cell vaccines modified with live but avirulent newcastle disease virus

P. Schlag, P. Hohenberger, P. Möller, 1990, Cancer.

First "Real-World" Insights on Apremilast Treatment for Patients with Plaque Psoriasis from the LAPIS-PSO Study: An Interim Analysis

K. Reich, B. Korge, Stefanie Bomas, 2017 .

Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial.

P. Schlag, C. Herfarth, P. Hohenberger, 1995, Cancer immunology, immunotherapy : CII.

Active specific immunotherapy with Newcastle-diseasevirus-modified autologous tumor cells following resection of liver metastases in colorectal cancer

P. Schlag, C. Herfarth, P. Hohenberger, 1992, Cancer Immunology, Immunotherapy.